28.11.2014 Views

2010 AnnuAl REpoRT - Ciberdem

2010 AnnuAl REpoRT - Ciberdem

2010 AnnuAl REpoRT - Ciberdem

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Name of the participants: A Lecube (researcher), J Mesa<br />

(coordinator)<br />

Tratamiento combinado de insulina glargina o sitagliptina<br />

en pacientes con diabetes tipo 2, no controlados<br />

suficientemente con un tratamiento previo con metformina<br />

y con insulina glargina o sitagliptina. EXT_LANTU_ C<br />

_02761. Phase III/IV<br />

Sanofi-Aventis: 2009-<strong>2010</strong><br />

Name of the participant: J Mesa (researcher)<br />

A 52 week randomised, controlled, open label, multicentre,<br />

multinational treat-to-target trial comparing efficacy and<br />

safety of SIBA and insulin glargine both administered<br />

once daily in a basal-bolus regimen with insulin aspart as<br />

mealtime insulin + treatment with metformin, + pioglitazone<br />

or both in subjects with type 2 diabetes currently treated<br />

with insulin qualifying for intensified treatment. NN1250-<br />

3582. Phase III<br />

Novo Nordisk SA: 2009-<strong>2010</strong><br />

Name of the participant: J Mesa (researcher)<br />

A 78 week open label extension to trials assessing the safety<br />

and efficacy of BI 10773 as monotherapy or in combination<br />

with Metformin in type 2 diabetic patients. 1245.24. Phase III<br />

Boehringer Ingelheim: 2009-<strong>2010</strong><br />

Name of the participant: J Mesa (researcher)<br />

An open label extension to trials assessing the safety and<br />

efficacy of BI 10773 as monotherapy in type 2 diabetic<br />

patients. 1245.25. Phase III<br />

Boehringer Ingelheim: <strong>2010</strong>-2014<br />

Name of the participant: J Mesa (researcher)<br />

Estudio multicéntrico aleatorizado, doble ciego y controlado<br />

con placebo para evaluar resultados cardiovasculares<br />

después del tratamiento con alogliptina en combinación<br />

con la asistencia habitual en sujetos con diabetes tipo2 y<br />

síndrome coronario agudo. SYR-322_302. Phase III<br />

Takeda Global Resarch: 2009-2013<br />

Name of the participant: J Mesa (researcher)<br />

Awards<br />

Premio Dr. Josep Trueta a la trayectoria de investigación<br />

dentro del ámbito de las Ciencias de la Salud, Academia<br />

de Ciencias Médicas y de la Salud de Catalunya y Baleares<br />

(<strong>2010</strong>)<br />

Awardee: Rafael Simó<br />

Premio Sanofi Aventis a la trayectoria en diabetes para<br />

jóvenes endocrinólogos, Fundación Sociedad Española de<br />

Endocrinología y Nutrición (<strong>2010</strong>)<br />

Awardee: Albert Lecube ■<br />

80 CibeRdem

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!